GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Control Bionics CBL.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.05

+2.04%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Control Bionics — daily ASX:CBL

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Control Bionics on TradingView ↗
Market value
A$20.6m
Last close × shares
Volume
96.2k
Shares, 9 Nov 2026

About Control Bionics

Its shares trade on ASX under the ticker CBL.AX. It has been listed since 7 December 2020. In the fiscal year to 30 June 2025, it reported revenue of A$7.0m and a net loss of A$6.1m. At that date it held total assets of A$8.2m and shareholders' equity of A$5.5m.

Control Bionics Ltd. engages in the manufacture, design, and sale of wireless wearable electromyography (EMG) based augmentative and alternative communication (AAC) technology. The company assists patients whose ability to communicate verbally or through text and social media is compromised by illnesses, such as motor neuron disease, amyotrophic lateral sclerosis, and others. Its NeuroNode technology is a wireless wearable device that detects minute signals sent from the brain to any skeletal muscle and is captured as Electromyography output. This output is then sent wirelessly through the NeuroNode to a personal computer, enabling speech and other computer-controlled functions, such as email and texting. Its core systems include NeuroNode Trilogy, NeuroNode Duo, Eye-gaze Duo, and DROVE. Its technology is integrated with eye-gaze technology, whereby the eye gaze enables a cursor to be moved on a computer screen, driven like a mouse, and the NeuroNode acts like the mouse button.

Figures and description from our data supplier, not checked against the company's own report.

More about Control Bionics →

How it makes its money

Revenue, year to 31 Dec 2025

  • Operating Expense Reimbursements [Member] A$7.7m · 47.6%
  • Management, Development and Leasing Fees [Member] A$5.1m · 31.5%
  • Marketing [Member] A$3.4m · 20.9%

Latest on Control Bionics

Our reporting

We have not reported on Control Bionics yet.

Next results

24 Feb 2027

Due on 24 Feb 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Control Bionics's ticker?

Control Bionics trades as CBL.AX on ASX, under ISIN AU0000114183.

What was Control Bionics's last closing price?

0.05 on 9 Nov 2026. The figure is in AUD and is never converted.

When does Control Bionics next report results?

Results are expected on 24 Feb 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.